These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33682487)

  • 1. Multifocal lipoatrophy secondary to insulin injection in a patient with type 2 diabetes, hepatitis B virus infection, and liver cirrhosis.
    Wu Y; Lou X
    J Int Med Res; 2021 Mar; 49(3):300060521990237. PubMed ID: 33682487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human recombinant DNA insulin-induced lipoatrophy in a patient with type 2 diabetes mellitus.
    Mu L; Goldman JM
    Endocr Pract; 2000; 6(2):151-2. PubMed ID: 11421532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-induced localized lipoatrophy.
    Breznik V; Kokol R; Luzar B; Miljković J
    Acta Dermatovenerol Alp Pannonica Adriat; 2013 Dec; 22(4):83-5. PubMed ID: 24336944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection.
    Caronia S; Taylor K; Pagliaro L; Carr C; Palazzo U; Petrik J; O'Rahilly S; Shore S; Tom BD; Alexander GJ
    Hepatology; 1999 Oct; 30(4):1059-63. PubMed ID: 10498660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-induced localized lipoatrophy preceded by shingles (herpes zoster): a case report.
    Chantelau EA; Prätor R; Prätor J
    J Med Case Rep; 2014 Jun; 8():223. PubMed ID: 24961832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic myonecrosis in a patient with hepatitis B-induced liver cirrhosis.
    Park SM; Kim YJ; Kim SM; Han N; Lee EJ; Kim TK; Kim TN; Kwon MJ; Kim MK; Lee SH; Park JH; Rhee BD; Kim BM; Lee SJ
    Can J Diabetes; 2015 Feb; 39(1):10-3. PubMed ID: 25305801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should adults with diabetes mellitus be vaccinated against hepatitis B virus? A systematic review of diabetes mellitus and the progression of hepatitis B disease.
    Younossi Z; Kochems K; de Ridder M; Curran D; Bunge EM; de Moerlooze L
    Hum Vaccin Immunother; 2017 Nov; 13(11):2695-2706. PubMed ID: 28742983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe localized lipoatrophy related to therapy with insulin analogs in type 1a diabetes mellitus.
    Peteiro-González D; Fernández-Rodríguez B; Cabezas-Agrícola JM; Araújo-Vilar D
    Diabetes Res Clin Pract; 2011 Mar; 91(3):e61-3. PubMed ID: 21146887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 diabetes: a risk factor for liver mortality and complications in hepatitis B cirrhosis patients.
    Hsiang JC; Gane EJ; Bai WW; Gerred SJ
    J Gastroenterol Hepatol; 2015 Mar; 30(3):591-9. PubMed ID: 25250942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pan-insulin allergy and severe lipoatrophy complicating Type 2 diabetes.
    Tavare AN; Doolittle HJ; Baburaj R
    Diabet Med; 2011 Apr; 28(4):500-3. PubMed ID: 21392071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
    Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
    World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of lipoatrophy with insulin detemir.
    Del Olmo MI; Campos V; Abellán P; Merino-Torres JF; Piñón F
    Diabetes Res Clin Pract; 2008 Apr; 80(1):e20-1. PubMed ID: 18281121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoatrophy induced by recombinant human insulin injection.
    Murao S; Hirata K; Ishida T; Takahara J
    Intern Med; 1998 Dec; 37(12):1031-3. PubMed ID: 9932635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoatrophy with insulin analogues in type I diabetes.
    Babiker A; Datta V
    Arch Dis Child; 2011 Jan; 96(1):101-2. PubMed ID: 20570843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoatrophy associated with rapid-acting insulin analogues in young patients with type 1 diabetes mellitus.
    Szypowska A; Skórka A; Pańkowska E
    Pediatr Endocrinol Diabetes Metab; 2008; 14(2):117-8. PubMed ID: 18721499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on the risk of hepatitis B-related cirrhosis combined with type 2 diabetes mellitus for the occurrence of primary hepatocellular carcinoma].
    Zhang LL; Li YF; Zhang C; Wu XF; Ma Y; Li L
    Zhonghua Gan Zang Bing Za Zhi; 2019 Oct; 27(10):788-792. PubMed ID: 31734994
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipoatrophy in children with type 1 diabetes: an increasing incidence?
    Kordonouri O; Biester T; Schnell K; Hartmann R; Tsioli C; Fath M; Datz N; Danne T
    J Diabetes Sci Technol; 2015 Mar; 9(2):206-8. PubMed ID: 25411060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human insulin-induced lipoatrophy. Successful treatment using a jet-injection device.
    Logwin S; Conget I; Jansa M; Vidal M; Nicolau C; Gomis R
    Diabetes Care; 1996 Mar; 19(3):255-6. PubMed ID: 8742573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipoatrophy after insulin injections can be treated with lipofilling].
    Lund PS; Sjøstrand H; Matzen SH
    Ugeskr Laeger; 2016 Dec; 178(49):. PubMed ID: 27959262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distant site lipoatrophy: a rare complication of subcutaneous insulin therapy.
    Chakraborty PP; Biswas SN
    Postgrad Med J; 2016 Jan; 92(1083):57-8. PubMed ID: 26561591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.